As ADT/ARSIs primarily target AR-expressing (AR+) PCa cells and interfere with AR signal transduction, one of the major molecular mechanisms driving ADT/ARSI resistance, understandably, involves the structural alterations of AR itself and expression of ligand-independent AR splice variants called AR-V’s [36]. This evidence concerns the gene AR and posterior cortical atrophy.